Apremile 10 Tablet contains Apremilast 10 mg, a selective phosphodiesterase 4 (PDE4) inhibitor that works as an immunomodulator to regulate inflammatory pathways. It is widely used for psoriasis, psoriatic arthritis, and other inflammatory autoimmune conditions.
By inhibiting PDE4, Apremilast reduces the production of pro-inflammatory cytokines, helping control skin inflammation, joint pain, and swelling. Its oral tablet formulation ensures systemic action with ease of administration.
Clinically, Apremile 10 Tablet is indicated for mild to moderate plaque psoriasis, active psoriatic arthritis, and related inflammatory conditions, providing symptom relief and improved patient quality of life.
The tablet offers reliable dosing, convenient oral use, and enhanced patient compliance, making it suitable for hospital, clinic, and outpatient care settings for long-term autoimmune management.